Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Marc Viscogliosi's photo - Chairman & CEO of Spine BioPharma

Chairman & CEO

Marc Viscogliosi

CEO Approval Rating

90/100

Read more